Toxicological characteristics of tablets with an extract of Potentilla alba L. with repeated administration to rabbits

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Relevance. In recent years, there has been increased interest in medicinal plants, in particular, Potentilla alba L., used for the treatment of endocrine diseases, on the basis of which the thyroid drug - tablets for oral administration, containing 0,150 g of dry extract of roots and rhizomes of this plant. The dry extract of rhizomes and roots of Potentilla alba L. normalizes the functional activity of the thyroid gland, has an immunomodulatory and hypolipidemic effect in the rat model of experimental hypothyroidism.

Aim. A study of the toxicity of tablets with dry extract of Potentilla alba L. with repeated administration to justify the conduct of clinical trials.

Material and methods. The study of general toxic effects of tablets was carried out on 15 clinically healthy male rabbits of Soviet Chinchilla breed, which were given tablets in doses of 37,5 and 75 mg/kg for 90 days. Control animals received placebo tablets. Integral, hematological and biochemical parameters were recorded, electrocardiograms (ECG) were taken, and pathohistological studies were performed to detect health abnormalities.

Results. Administration of tablets at 9- and 17-fold therapeutic doses had no effect on basic hematological, biochemical and ECG parameters characterizing functional state of liver, kidneys, cardiovascular system of experimental animals. Administration of tablets to rabbits in the tested doses caused a moderate dose-dependent decrease in their body weight gain, possibly related to the hypolipidemic effect. Pathohistological examination revealed changes that were dose-dependent: full-bloodedness of internal organs, including pituitary gland; stimulation of hematopoietic function characterized by increased spleen follicles and their confluence; inhibition of thyroid function and partially of spermatogenesis. At the maximum tested dose of 75 mg/kg, the studied drug had a selective specific pharmacological effect on the pituitary gland, causing a decrease in the size of basophilic cells. No irritating effect of the tablets on the mucosa of the gastrointestinal tract of animals was noted.

Conclusion. The obtained results of the preclinical toxicological examination of tablets 0.150 g were included in the dossier on the drug prepared for transfer to the Ministry of Health of the Russian Federation for obtaining permission to conduct clinical trials.

全文:

受限制的访问

作者简介

А. Babenko

All-Russian Scientific Research Institute of Medicinal and Aromatic Plants

编辑信件的主要联系方式.
Email: babenko@vilarnii.ru

Ph.D. (Biol.), Leading Research Scientist, Department of Toxicology

俄罗斯联邦, Moscow

L. Krepkova

All-Russian Scientific Research Institute of Medicinal and Aromatic Plants

Email: krepkowa2011@yandex.ru

Ph.D. (Biol.), Head of Toxicology Department

俄罗斯联邦, Moscow

S. Lemyaseva

All-Russian Scientific Research Institute of Medicinal and Aromatic Plants

Email: emyaseva.svetlana@yandex.ru

Ph.D. (Biol.), Leading Research Scientist, Department of Toxicology

俄罗斯联邦, Moscow

O. Kuzina

All-Russian Scientific Research Institute of Medicinal and Aromatic Plants

Email: oskt@list.ru

Senior Research Scientist, Toxicology Department

俄罗斯联邦, Moscow

M. Вorovkova

All-Russian Scientific Research Institute of Medicinal and Aromatic Plants

Email: orovkova_65@mail.ru

Senior Research Scientist, Toxicology Department

俄罗斯联邦, Moscow

O. Semkina

All-Russian Scientific Research Institute of Medicinal and Aromatic Plants

Email: semkina@vilarnii.ru

Ph.D. (Pharm.), Leading Research Scientist, Experimental Technology Department

俄罗斯联邦, Moscow

A. Sidelnikov

All-Russian Research Institute of Medicinal and Aromatic Plants

Email: sidelnikov@vilarnii.ru

Research Scientist, Department of Medical and Biological Problems

俄罗斯联邦, Moscow

参考

  1. Golden S.H., Robinson K.A., Saldanha I., Anton B., Ladenson P.W. Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J. Clin. Endocrinol. Metab. 2009; 94(6): 1853–1878. doi: 10.1210/jc.2008-2291.
  2. Faggiano A., Del Prete M., Marciello F., Marotta V., Ramundo V., Colao A. Thyroid diseases in elderly. Minerva Endocrinol. 2011; 36(3): 211–231.
  3. Tokarz J., Haid M., Cecil A., Prehn C., Artati A., Möller G., Adamski J. Endocrinology Meets Metabolomics: Achievements, Pitfalls, and Challenges. Trends Endocrinol. Metab. 2017; 28(10): 705–721. doi: 10.1016/j.tem.2017.07.001.
  4. Lovic D., Piperidou A., Zografou I., Grassos H., Pittaras A., Manolis A. The Growing Epidemic of Diabetes Mellitus. Curr. Vasc. Pharmacol. 2020;18(2): 104–109. doi: 10.2174/1570161117666190405165911.
  5. Li Y., Jin C., Li J., Tong M., Wang M., Huang J., Ning Y., Ren G. Prevalence of Thyroid Nodules in China: A Health Examination Cohort-Based Study. Front. Endocrinol. (Lausanne). 2021; 12:676144. doi: 10.3389/fendo.2021.676144.
  6. Kuznecov E.V., Zhukova L.A., Pahomova E.A., Gulamov A.A. Jendokrinnye zabolevanija kak mediko-social'naja problema sovremennosti. Sovremennye problemy nauki i obrazovanija. 2017; 4: 62.
  7. Mel'nichenko G.A., Troshina E.A., Platonova N.M., Savchuk P.O., Jakunchikova M.S. Osvedomlennost' naselenija Rossii o jododeficitnyh zabolevanijah i sposobah ih profilaktiki. Klinicheskaja i jeksperimental'naja tireoidologija. 2016; 12(3): 25–30.
  8. Vejcman I.A., Mazepa S.I. Osobennosti pitanija pri narushenijah funkcii shhitovidnoj zhelezy (obzor literatury). FOCUS Jendokrinologija. 2021; 3: 93–95. doi: 10.47407/ef2021.2.3.0041.
  9. Savina A.A. Tendencii pokazatelej zabolevaemosti boleznjami jendokrinnoj sistemy vzroslogo naselenija Rossijskoj Federacii. Social'nye aspekty zdorov'ja naselenija [setevoe izdanie]. 2021; 67(4): 6.
  10. American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes care. 2020; 43 (1): 14–31. doi: 10.2337/dc20-S002.
  11. Klinicheskie rekomendacii po diagnostike i lecheniju tireotoksikoza s diffuznym zobom (bolezn' Grejvsa), uzlovym/mnogouzlovym zobom. 2021: 50 s.
  12. Klinicheskie rekomendacii. Gipotireoz. 2021-2022-2023 (22.04.2021). Utverzhdeny Minzdravom RF. 2021.
  13. Dedov I.I., Mel'nichenko G.A. Jendokrinologija: nacional'noe rukovodstvo. Izd. 2-e, pererab. i dop. M.: GJeOTAR-Media. 2021; 1112 s.
  14. Verbovoj A.F., Dolgih Ju.A. Gipotireoz v praktike vracha-terapevta: slozhnosti diagnostiki i lechenija. Medicinskij sovet. 2019; (21): 206–212. doi: 10.21518/2079-701X-2019-21-206-212.
  15. Alefirov A.N. Fitoterapija zabolevanij shhitovidnoj zhelezy. SPb.: Feniks. 2008; 126 s.
  16. Sidelnikov N.I. Atlas lekarstvennyh rastenij Rossii. Izd. 2-e. pererab. i dop. M.: Nauka, VILAR. 2021; 646 s.
  17. Vodop'janova A.M, Arhipova Je.V., Shantanova L.N., Nikolaev S.M. Lapchatka belaja kak perspektivnoe sredstvo dlja lechenija zabolevanij shhitovidnoj zhelezy. Bjulleten'. VSNC SO RAMN. 2011; 1(77): 131–134.
  18. Kaminskij A.V., Kiseleva I.A., Teplaja E.V. Klinicheskie vozmozhnosti primenenija lapchatki beloj v profilaktike i lechenii patologii shhitovidnoj zhelezy. Jendokrinologija: novosti, mnenija, obuchenie. 2014; 1: 68–75.
  19. Augustynowicz D, Podolak M, Latté KP, Tomczyk M. New Perspectives for the Use of Potentilla alba Rhizomes to Treat Thyroid Gland Impairments. Planta Med. 2021; 10: 1055/a-1663–6461. doi: 10.1055/a-1663-6461.
  20. Semkina O.A., Kachalina T.V., Malysheva N.A., Sagaradze V.A., Burova A.E., Dzhavahjan M.A. Tehnologicheskie aspekty razrabotki tabletok suhogo jekstrakta lapchatki beloj. Voprosy biologicheskoj, medicinskoj i farmacevticheskoj himii. 2018; 21(12): 9–14. doi: 10.29296/25877313-2018-12-02.
  21. Semkina O.A., Dzhavahjan M.A., Kachalina T.V., Malysheva N.A., Meshkov A.I., Mondodoev A.G., Sidel'nikov A.N., Krepkova L.V., Ferubko E.V. Farmacevticheskaja kompozicija dlja profilaktiki i lechenija gipotireoza shhitovidnoj zhelezy. Patent RU №2708260. 24.07.2018 g.
  22. Arhipova Je.V., Vodop'janova A.M., Kolhir V.K. Vlijanie jekstrakta suhogo lapchatki beloj na techenie jeksperimental'nogo gipotireoza. Bjulleten' VSNC SO RAMN. 2011; 1(77): 116–118.
  23. Krepkova L.V., Babenko A.N, Lemjaseva S.V., Borovkovoj M.V., Kuzina O.S. Nekotorye aspekty doklinicheskogo izuchenija bezopasnosti lapchatki beloj (Potentilla alba L.) jekstrakta suhogo. Voprosy biologicheskoj, medicinskoj i farmacevticheskoj himii. 2022; 25(4): 40–47. doi: 10.29296/25877313-2022-04-06.
  24. Borovkova M.V., Krepkova L.V., Bortnikova V.V. Immunotoksicheskie i allergizirujushhie svojstva lapchatki beloj (Rotentilla alba L.) jekstrakta suhogo. Razrabotka i registracija lekarstvennyh sredstv. 2020; 9(4): 86–87. doi: 10.33380/2305-2066-2020-9-4(1)-16-161.
  25. Lemyaseva S.V., Krepkova L.V., Babenko A.N. Gipolipidemicheskoe dejstvie suhih rastitel'nyh ekstraktov na modeli giperlipidemii u krys. Sbornik trudov IX Mezhdunarodnoj nauchnoj konferencii molodyh uchenyh «Sovremennye tendencii razvitiya tekhnologij zdorov'esberezheniya», M., FGBNU VILAR, 16-17 dekabrya 2021. S. 452-458.
  26. Burova A.E., Sajbel' O.L., Meshkov A.I. Razrabotka metodik analiza fenol'nyh soedinenij kornevishh s kornjami lapchatki beloj (Potentilla alba L.). Voprosy obespechenija kachestva lekarstvennyh sredstv. 2016; 13 (3): 9–14.
  27. Krepkova L.V., Bortnikova V.V., Babenko A.N., Mizina P.G., Mkhitarov V.A., Job K.M., Sherwin C.M., Enioutina E.Y. Effects of a new thyrotropic drug isolated from Potentilla alba on the male reproductive system of rats and offspring development. BMC Complement. Med. Ther. 2021; 21(1): 31. doi: 10.1186/s12906-020-03184-z.

补充文件

附件文件
动作
1. JATS XML
2. Fig. 1

下载 (16KB)
3. Fig. 2

下载 (30KB)
4. Fig. 3

下载 (134KB)
5. Fig. 4

下载 (234KB)
##common.cookie##